ArticleAdvanced healthcare materials2026
A Modular Bioinstructive Platform Reveals Mechanistic Insights into Additive-Free, Topography-Driven Osteogenesis.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Developing physiologically relevant bone models is critical for drug discovery, disease modeling, and regenerative medicine, yet reproducing osteogenesis in vitro without biochemical induction remains a longstanding challenge. We present a scalable, bioinstructive microparticle platform in which engineered 3D surface topographies induce mesenchymal stem cell osteogenesis through topography-mediated mechanotransduction in the absence of exogenous additives. RNA-Seq and signaling analyses revealed a mechanistic sequence in which cytoskeletal reorganization activates canonical Hedgehog signaling, triggering early upregulation of cytoskeletal components and osteochondral transcription factors, including RUNX2 and SOX9, followed by IGF-II activation and osteogenic commitment. To demonstrate the potential of precision-engineered biomaterials for in vitro modeling, two-photon polymerization lithography was employed to engineer precisely-patterned 3D topographies with tunable dimensions, which elicited graded GLI1 expression without exogenous soluble factors. By decoupling mechanical microenvironments from chemical signaling, this establishes a scalable and modular strategy for reproducible control of cell fate, presenting a broadly applicable strategy for bioinstructive regenerative materials and standardized, additive-free bone models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.